Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease
T J Van Trier(Amsterdam University Medical Centers), H T Jørstad(Leyden Academy on Vitality and Ageing), Ron J.G. Peters(Amsterdam UMC Location University of Amsterdam), Marjolein Snaterse(Amsterdam University Medical Centers), Henrike Galenkamp(Amsterdam UMC Location University of Amsterdam), Madoka Sunamura(Sint Franciscus Gasthuis), Frank L.J. Visseren(University Medical Center Utrecht), Nienke ter Hoeve(Erasmus MC), Fabrice M A C Martens(Deventer Ziekenhuis), Jaap W. Deckers(Erasmus MC), Eric P. Moll van Charante(Amsterdam Neuroscience), Wilma J.M. Scholte op Reimer, Steven H J Hageman(University Medical Center Utrecht)
Cited by 14
Related Papers
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2021|6.1k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k